Literature DB >> 22527563

B16-F10 melanoma cells contribute to the new formation of blood vessels in the chick embryo chorioallantoic membrane through vasculogenic mimicry.

Domenico Ribatti1, Beatrice Nico, Anca Maria Cimpean, Marius Raica, Enrico Crivellato, Simona Ruggieri, Angelo Vacca.   

Abstract

Grafting of mammalian cells and tissues to the chick embryo chorioallantoic membrane (CAM) is a well-established experimental system to evaluate many different parameters of tumor growth, and B16-F10 murine melanoma cell line has been successfully used to study metastatic process in the CAM assay. The aim of this study was to demonstrate the capability of B16-F10 melanoma cells to contribute to the new formation of host blood vessels through a vasculogenic mimicry mode. Results have shown that B16-F10 melanoma cells are able to form in 4 days macroscopic tumor masses and induce a strong angiogenic response comparable to that of a well-known angiogenic cytokine, namely fibroblast growth factor-2. Moreover, tumor cells are able to cross the chorionic epithelium, and to move beneath in the mesenchyme to form tumor masses immunoreactive to specific antibodies anti-S100 and anti-MART-1/Melan-A. Finally, we have shown that CAMs new-formed blood vessels are lined by both pigmented melanoma cells and cells immunoreactive to MART-1/Melan-A and PAS, suggesting the occurrence of a vasculogenic mimicry process.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22527563     DOI: 10.1007/s10238-012-0183-8

Source DB:  PubMed          Journal:  Clin Exp Med        ISSN: 1591-8890            Impact factor:   3.984


  25 in total

1.  Increased melanoma growth and metastasis spreading in mice overexpressing placenta growth factor.

Authors:  Marcella Marcellini; Naomi De Luca; Teresa Riccioni; Alessandro Ciucci; Angela Orecchia; Pedro Miguel Lacal; Federica Ruffini; Maurizio Pesce; Francesca Cianfarani; Giovanna Zambruno; Augusto Orlandi; Cristina Maria Failla
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

2.  Neovascularisation, expression of fibroblast growth factor-2, and mast cells with tryptase activity increase simultaneously with pathological progression in human malignant melanoma.

Authors:  D Ribatti; A Vacca; R Ria; A Marzullo; B Nico; R Filotico; L Roncali; F Dammacco
Journal:  Eur J Cancer       Date:  2003-03       Impact factor: 9.162

3.  Molecular determinants of ovarian cancer plasticity.

Authors:  A K Sood; E A Seftor; M S Fletcher; L M Gardner; P M Heidger; R E Buller; R E Seftor; M J Hendrix
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

4.  VEGFR-1 expressed by malignant melanoma-initiating cells is required for tumor growth.

Authors:  Natasha Y Frank; Tobias Schatton; Soo Kim; Qian Zhan; Brian J Wilson; Jie Ma; Karim R Saab; Veronika Osherov; Hans R Widlund; Martin Gasser; Ana-Maria Waaga-Gasser; Thomas S Kupper; George F Murphy; Markus H Frank
Journal:  Cancer Res       Date:  2011-01-06       Impact factor: 12.701

5.  Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry.

Authors:  A J Maniotis; R Folberg; A Hess; E A Seftor; L M Gardner; J Pe'er; J M Trent; P S Meltzer; M J Hendrix
Journal:  Am J Pathol       Date:  1999-09       Impact factor: 4.307

6.  Microvascular density, vascular endothelial growth factor immunoreactivity in tumor cells, vessel diameter and intussusceptive microvascular growth in primary melanoma.

Authors:  Domenico Ribatti; Beatrice Nico; Carlo Floris; Domenica Mangieri; Franca Piras; Maria Grazia Ennas; Angelo Vacca; Paola Sirigu
Journal:  Oncol Rep       Date:  2005-07       Impact factor: 3.906

7.  An alternative in vivo system for testing angiogenic potential of human neuroblastoma cells.

Authors:  Domenica Mangieri; Beatrice Nico; Addolorata M L Coluccia; Angelo Vacca; Mirco Ponzoni; Domenico Ribatti
Journal:  Cancer Lett       Date:  2009-01-17       Impact factor: 8.679

8.  Overexpression of metalloproteinase inhibitor in B16F10 cells does not affect extravasation but reduces tumor growth.

Authors:  S Koop; R Khokha; E E Schmidt; I C MacDonald; V L Morris; A F Chambers; A C Groom
Journal:  Cancer Res       Date:  1994-09-01       Impact factor: 12.701

9.  Fate of melanoma cells entering the microcirculation: over 80% survive and extravasate.

Authors:  S Koop; I C MacDonald; K Luzzi; E E Schmidt; V L Morris; M Grattan; R Khokha; A F Chambers; A C Groom
Journal:  Cancer Res       Date:  1995-06-15       Impact factor: 12.701

10.  Clinical significance of vasculogenic mimicry in human gliomas.

Authors:  Xiao-mei Liu; Qing-ping Zhang; Yong-gao Mu; Xiang-hen Zhang; Ke Sai; Jesse Chung-Sean Pang; Ho-Keung Ng; Zhong-ping Chen
Journal:  J Neurooncol       Date:  2011-04-30       Impact factor: 4.130

View more
  6 in total

1.  Inactivation of the mTORC1-eukaryotic translation initiation factor 4E pathway alters stress granule formation.

Authors:  Marie-Josée Fournier; Laetitia Coudert; Samia Mellaoui; Pauline Adjibade; Cristina Gareau; Marie-France Côté; Nahum Sonenberg; René C Gaudreault; Rachid Mazroui
Journal:  Mol Cell Biol       Date:  2013-04-01       Impact factor: 4.272

Review 2.  The chicken chorioallantoic membrane model in biology, medicine and bioengineering.

Authors:  Patrycja Nowak-Sliwinska; Tatiana Segura; M Luisa Iruela-Arispe
Journal:  Angiogenesis       Date:  2014-08-20       Impact factor: 9.596

3.  The CAM Assay as an Alternative In Vivo Model for Drug Testing.

Authors:  Regine Schneider-Stock; Domenico Ribatti
Journal:  Handb Exp Pharmacol       Date:  2021

4.  Standardization of A375 human melanoma models on chicken embryo chorioallantoic membrane and Balb/c nude mice.

Authors:  Stefana Avram; Dorina-Elena Coricovac; Ioana Zinuca Pavel; Iulia Pinzaru; Roxana Ghiulai; Flavia Baderca; Codruta Soica; Danina Muntean; Daciana E Branisteanu; Demetrios A Spandidos; Aristides M Tsatsakis; Cristina Adriana Dehelean
Journal:  Oncol Rep       Date:  2017-05-22       Impact factor: 3.906

Review 5.  Microvascular Experimentation in the Chick Chorioallantoic Membrane as a Model for Screening Angiogenic Agents including from Gene-Modified Cells.

Authors:  Donna C Kennedy; Barbara Coen; Antony M Wheatley; Karl J A McCullagh
Journal:  Int J Mol Sci       Date:  2021-12-31       Impact factor: 5.923

6.  Phenotype-dependent effects of EpCAM expression on growth and invasion of human breast cancer cell lines.

Authors:  Agnieszka Martowicz; Gilbert Spizzo; Guenther Gastl; Gerold Untergasser
Journal:  BMC Cancer       Date:  2012-10-30       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.